Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Post by Dachs1on Apr 10, 2016 10:58am

118 Views

Post# 24749375

new target group for Skin Lightening -> Brazil!!!

Global market trend towards skin lightening cosmetics reaches Brazil

Women aged from 30 to 60 are the biggest consumers of products to lighten the skin and even out its tone.

https://www.brazilbeautynews.com/global-market-trend-towards-skin-lightening,877

Freckles and skin spots can appear as a result of excessive sun exposure, hormonal changes or simply be a visible reminder of the passing of time. They are one of the main beauty concerns of Brazilian women, behind only dark circles and “crow’s feet”, those dreaded branching wrinkles at the outer corner of the eyes. Although Brazilians love having a tan, they are increasingly looking for products that claim to lighten the skin and even out the skin tone.